Emmerich J - Search Results

1

Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutation.

Le Cam-Duchez V, Gandrille S, Trégouët D, Alhenc-Gelas M, Emmerich J, Fiessinger JN, Borg JY, Aiach M. Le Cam-Duchez V, et al. Among authors: emmerich j. Br J Haematol. 1999 Sep;106(4):889-97. doi: 10.1046/j.1365-2141.1999.01661.x. Br J Haematol. 1999. PMID: 10519989 Free article.

2

Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VI.

Gandrille S, Vidaud D, Emmerich J, Clauser E, Sié P, Fiessinger JN, Alhenc-Gelas M, Priollet P, Aiach M. Gandrille S, et al. Among authors: emmerich j. Br J Haematol. 1991 Jul;78(3):414-20. doi: 10.1111/j.1365-2141.1991.tb04457.x. Br J Haematol. 1991. PMID: 1873224

3

Protein C infusion in a patient with inherited protein C deficiency caused by two missense mutations: Arg 178 to Gln and Arg-1 to His.

Alhenc-Gelas M, Emmerich J, Gandrille S, Aubry ML, Benaily N, Fiessinger JN, Aiach M. Alhenc-Gelas M, et al. Among authors: emmerich j. Blood Coagul Fibrinolysis. 1995 Feb;6(1):35-41. doi: 10.1097/00001721-199502000-00006. Blood Coagul Fibrinolysis. 1995. PMID: 7795152 Review.

4

[Activated protein C resistance: role in venous and arterial thrombosis].

Emmerich J, Alhenc-Gelas M, Aiach M, Fiessinger JN. Emmerich J, et al. Arch Mal Coeur Vaiss. 1996 Jun;89(6):741-5. Arch Mal Coeur Vaiss. 1996. PMID: 8760661 Review. French.

5

Resistance to activated protein C: role in venous and arterial thrombosis.

Emmerich J, Alhenc-Gelas M, Aiach M, Fiessinger JN. Emmerich J, et al. Biomed Pharmacother. 1996;50(6-7):254-60. doi: 10.1016/0753-3322(96)84822-0. Biomed Pharmacother. 1996. PMID: 8952864 Review.

6

Clinical features in 36 patients homozygous for the ARG 506-->GLN factor V mutation.

Emmerich J, Alhenc-Gelas M, Aillaud MF, Juhan-Vague I, Jude B, Garcin JM, Dreyfus M, de Moerloose P, Le Querrec A, Priollet P, Berruyer M, Vallantin X, Wolf M, Aiach M, Fiessinger JN. Emmerich J, et al. Thromb Haemost. 1997 Apr;77(4):620-3. Thromb Haemost. 1997. PMID: 9134631

7

The factor V gene A4070G mutation and the risk of venous thrombosis.

Alhenc-Gelas M, Nicaud V, Gandrille S, van Dreden P, Amiral J, Aubry ML, Fiessinger JN, Emmerich J, Aiach M. Alhenc-Gelas M, et al. Among authors: emmerich j. Thromb Haemost. 1999 Feb;81(2):193-7. Thromb Haemost. 1999. PMID: 10063990

8

Mutations in promoter region of thrombomodulin and venous thromboembolic disease.

Le Flem L, Picard V, Emmerich J, Gandrille S, Fiessinger JN, Aiach M, Alhenc-Gelas M. Le Flem L, et al. Among authors: emmerich j. Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):1098-104. doi: 10.1161/01.atv.19.4.1098. Arterioscler Thromb Vasc Biol. 1999. PMID: 10195941

9

Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.

Alhenc-Gelas M, Arnaud E, Nicaud V, Aubry ML, Fiessinger JN, Aiach M, Emmerich J. Alhenc-Gelas M, et al. Among authors: emmerich j. Thromb Haemost. 1999 Apr;81(4):506-10. Thromb Haemost. 1999. PMID: 10235429

10

Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk.

Aiach M, Nicaud V, Alhenc-Gelas M, Gandrille S, Arnaud E, Amiral J, Guize L, Fiessinger JN, Emmerich J. Aiach M, et al. Among authors: emmerich j. Arterioscler Thromb Vasc Biol. 1999 Jun;19(6):1573-6. doi: 10.1161/01.atv.19.6.1573. Arterioscler Thromb Vasc Biol. 1999. PMID: 10364092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters